ICU sedation, delirium & recovery

Volatile Anesthetics: A Comprehensive Review of Pharmacology, Delivery Systems, and Safety Considerations for ICU Practitioners

Crit Care MedPublished Narrative review

Authors' conclusion

VAs can be used as sedative agents in the ICU.

Study context

Population
Adult ICU patients receiving volatile anesthetic sedation
Methodological detailsLiterature identified through PubMed and MEDLINE; original research, reviews, commentaries and guidelines on volatile anesthetics (VAs) in adult ICU patients included
  • Literature identified through PubMed and MEDLINE; original research, reviews, commentaries and guidelines on VAs in adult ICU patients included

Main finding

As reported in the abstract

  • VAs are halogenated hydrocarbons; mechanism of action not fully understood; CNS is primary site of action
  • End-tidal concentration of exhaled anesthetic used to monitor clinical effects
  • Unique pharmacokinetics, minimal metabolism, distinct recovery
  • Two inhalational sedation delivery systems available internationally, one under evaluation in the US; composed of miniature vaporizer, delivery controller and monitor

Safety

Side effect profile

Malignant hyperthermia the most feared, yet rare complication
Delivery systems have distinct safety considerations, e.g. tidal volume limits

Original publication

Volatile Anesthetics: A Comprehensive Review of Pharmacology, Delivery Systems, and Safety Considerations for ICU Practitioners. Crit Care Med. Published 16 January 2026. doi:10.1097/ccm.0000000000007042

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.